AAAAAA
Results:
1-8
|
Results: 8
Authors:
Gloor, M
Bakwin, P
Hurst, D
Lock, L
Draxler, R
Tans, P
Citation: M. Gloor et al., What is the concentration footprint of a tall tower?, J GEO RES-A, 106(D16), 2001, pp. 17831-17840
Authors:
Dyken, RA
Sadowsky, L
Hurst, D
Citation: Ra. Dyken et al., Orthodontic outcomes assessment using the Peer Assessment Rating Index, ANGL ORTHOD, 71(3), 2001, pp. 164-169
Authors:
Powell, JS
Bush, M
Harrison, J
Abildgaard, C
Vosburgh, E
Thompson, AR
Hurst, D
Citation: Js. Powell et al., Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A, HAEMOPHILIA, 6(3), 2000, pp. 140-149
Authors:
Hurst, D
Citation: D. Hurst, Haemophilia A gene therapy using retroviral vectors, HAEMOPHILIA, 6, 2000, pp. 13-14
Authors:
Wright, ED
Hurst, D
Miotto, D
Giguere, C
Hamid, Q
Citation: Ed. Wright et al., Increased expression of major basic protein (MBP) and interleukin-5 (IL-5)in middle ear biopsy specimens from atopic patients with persistent otitismedia with effusion, OTO H N SUR, 123(5), 2000, pp. 533-538
Authors:
Zhao, CF
Shi, SH
Mir, D
Hurst, D
Li, RS
Xiao, XY
Lillig, J
Czarnik, AW
Citation: Cf. Zhao et al., Polystyrene grafted fluoropolymer microtubes: New supports for solid-phaseorganic synthesis with useful performance at high temperature, J COMB CHEM, 1(1), 1999, pp. 91-95
Authors:
Seremetis, S
Lusher, JM
Abildgaard, CF
Kasper, CK
Allred, R
Hurst, D
Citation: S. Seremetis et al., Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy, HAEMOPHILIA, 5(1), 1999, pp. 9-16
Authors:
Hurst, D
Zabor, S
Malianni, D
Miller, D
Citation: D. Hurst et al., Evaluation of recombinant factor VIII (Kogenate (R)) stability for continuous infusion using a minipump infusion device, HAEMOPHILIA, 4(6), 1998, pp. 785-789
Risultati:
1-8
|